This page shows the latest Bydureon BCise news and features for those working in and with pharma, biotech and healthcare.
The new once-weekly formulation called Bydureon BCise uses a new simpler injection device, and was approved in the US in October. ... Sales of Bydureon shrank 2% in the first half of 2018, thanks to a combination of US pricing pressure and growing
Its latest injectable suspension proven to reduce blood sugar levels. AstraZeneca’s newly formulated Bydureon BCise (exenatide extended-release) has received US approval from the Food and Drug Administration (FDA) for ... reduction. Ruud Dobber,
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...